Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
139.1 USD | +6.25% | +3.78% | -22.87% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.87% | 14.52B | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.26% | 22.19B | |
-16.16% | 21.33B | |
-7.47% | 18.68B | |
-41.41% | 16.6B | |
+6.32% | 14.09B | |
+21.46% | 10.99B | |
-21.14% | 8.63B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : Brukinsa Approved in Australia for Mantle Cell Lymphoma